
Pramitrem 0.26mg Tablet XR
Marketer
Dr Reddy's Laboratories Ltd
Salt Composition
Pramipexole (0.26mg)
Overview Pramitrem 0.26mg Tablet XR
Extended-release Pramitrem 0.26mg tablets manage Parkinson's disease symptoms and restless legs syndrome (characterized by an irresistible urge to move legs due to unpleasant sensations). This medication reduces excessive tremors by moderating movement. Administer Pramitrem 0.26mg XR with food, consistently at the same time daily for optimal blood levels. Follow your doctor's prescribed dosage and duration. If a dose is missed, take it immediately upon recall. Complete the entire course, even if feeling improved, and avoid abrupt cessation without consulting your physician. Common side effects include nausea, dry mouth, tiredness, visual disturbances, constipation, and swelling in the extremities. Drowsiness and dizziness may occur; avoid activities requiring alertness until the medication's effects are known. Report any unusual mood shifts, heightened libido, compulsive gambling, or excessive spending to your doctor, as these can be serious.
Uses of Pramitrem 0.26mg Tablet XR
Parkinson's disease and restless legs syndrome
Major Benefits of Pramitrem 0.26mg Tablet XR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Pramitrem 0.26mg Extended-Release tablet should be administered with food.
Common Side effects of Pramitrem 0.26mg Tablet XR:
- Dizziness
- Sleepiness
- Nausea
- Dryness in mouth
- Fatigue
- Hallucination
- Constipation
- Peripheral edema
- Muscle spasm
How to use Pramitrem 0.26mg Tablet XR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Pramitrem 0.26mg Extended-Release Tablet with food.
How Pramitrem 0.26mg Tablet XR works:
Pramitrem XR 0.26mg tablets function by replicating the effects of dopamine, a neurotransmitter crucial for regulating motor control within the brain.
SAFETY ADVICE
AlcoholUNSAFE
Extended-release Pramitrem 0.26mg tablets can induce pronounced sleepiness when combined with alcohol.
PregnancyCONSULT YOUR DOCTOR
Extended-release Pramitrem 0.26mg tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Pramitrem 0.26mg tablets are likely unsafe for breastfeeding mothers. Scant evidence from human studies indicates potential drug transfer to breast milk, posing a risk to the infant. The medication's prolactin-suppressing action could negatively impact lactation.
DrivingUNSAFE
Extended-release Pramitrem 0.26mg tablets may induce adverse reactions impacting driving capabilities. These reactions can include hallucinations, such as perceiving nonexistent sights, sounds, or sensations, thereby potentially impairing driving skills.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Pramitrem 0.26mg extended-release tablets. Dosage modification may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Extended-release Pramitrem 0.26mg tablets appear to pose minimal risk for individuals with hepatic impairment. Current evidence indicates dose modification may be unnecessary; however, physician consultation is advised.
What if you forget to take Pramitrem 0.26mg Tablet XR :
Omit any missed Pramitrem 0.26mg extended-release tablet and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Pramitrem 0.26mg Tablet XR
| Label | Value |
|---|---|
| Chemical Category | Benzothiazole compound |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Actions | Dopamine-stimulating medications |
